ELUT
ELUTIA INC.
NASDAQ · Healthcare · Biotechnology · US
$0.85
+0.00%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$0.15
- Revenue estimate
- $1.0M
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$0.17
- EPS estimate
- -$0.15
- Revenue actual
- $2.4M
- Revenue estimate
- $2.9M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 3
- EPS misses (12Q)
- 8
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +16.7%
- Revenue beats (12Q)
- 2
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | -$0.15 | -$0.17 | Miss -13.33% | $2.4M |
| May 14, 2026 | -$0.15 | -$0.17 | Miss -13.33% | $3.1M |
| Mar 11, 2026 | -$0.14 | -$0.14 | In line | -$3.3M |
| Nov 6, 2025 | -$0.15 | -$0.01 | Beat 93.55% | $3.3M |
| Aug 14, 2025 | -$0.17 | -$0.26 | Miss -52.94% | $6.3M |
| May 8, 2025 | -$0.20 | -$0.21 | Miss -5.00% | $6.0M |
| Mar 6, 2025 | -$0.25 | -$0.26 | Miss -4.00% | $5.5M |
| Nov 14, 2024 | -$0.44 | -$0.33 | Beat 25.00% | $5.9M |
| May 9, 2024 | -$0.41 | -$0.75 | Miss -82.93% | $6.7M |
| Mar 7, 2024 | -$0.28 | -$0.66 | Miss -135.71% | $5.9M |
| Nov 13, 2023 | -$0.53 | -$0.50 | Beat 5.66% | $6.1M |
| Aug 14, 2023 | -$0.29 | -$0.65 | Miss -124.14% | $10.3M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026